biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Time Warp

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Nov 09, 2022 1:58am

86 Views

Post# 35084226

RE:RE:RE:RE:RE:RE:Time Warp

Don't just talk about making your case, uncle. Make your case.

How much time do you want?

Three days?

If you post something besides whining and telling me to stop, then I'll address your posts. But you're not saying anything. You're just stamping your feet and crying.

Make your case. Arguments, maybe some facts, research, on-topic opinions, logic, anything.

jd

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario